Delivery Order SPE2DX15D3012-SPE2DX23F8PS2
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,999.82 firm fixed-price delivery order is for the supply of Ondansetron orally disintegrating tablets, 4 mg, in 30-count packs. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,999.76 firm fixed-price delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets. The contract has an ultimate completion date of April 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,643.99 firm fixed-price delivery order contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,982.89 firm fixed-price delivery order is for the procurement of 4,566,409,405 units of the drug Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,911.23, is a Firm Fixed Price Delivery Order for the supply of 4 mg Ondansetron Orally Disintegrating Tablets. The contract has an ultimate completion date of March 3, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,011.20 firm fixed-price delivery order is for the supply of 4 mg ondansetron orodispersible tablets (ODT) in quantities of 30. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron orally disintegrating tablets. The $25,557.16 firm fixed-price contract has a completion date of May 13, 2024. AmerisourceBergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,826.75, is for the delivery of Ondansetron Orally Disintegrating Tablets, 8 mg, in quantities of 30 per package. This is a firm fixed price delivery order contract with no set-aside designation, meaning it was competed openly. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,562,880 units of 8 mg Ondansetron Orally Disintegrating Tablets, with a ceiling value of $12,687.40 and a completion date of November 22, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4 mg Ondansetron Orally Disintegrating Tablets, with a ceiling value of $3,263.98 and a completion date of January 2, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- SPE2DX15D3012Indefinite Delivery Contract
- SPE2DX15D3012-SPE2DX23F8PS2Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,979.28 firm fixed-price delivery order is for the supply of 30 count packages of 8 mg Ondansetron Orally Disintegrating Tablets. The contract has an ultimate completion date of May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies. This contract award was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 5/11/23 |